Locations
San Francisco, CA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Seed
founded in
2018
Deciduous Therapeutics is an innovative biotechnology company focused on enhancing human health span through the development of novel immune-modulatory therapies that target and eliminate senescent cells, which are implicated in various age-related diseases. By harnessing the body's own immune mechanisms, Deciduous aims to provide transformative treatments that improve health outcomes and quality of life for aging populations. The company is led by a team of experienced scientists and entrepreneurs, including CEO Robin Mansukhani and scientific founder Anil Bhushan, who have a strong background in drug discovery and development. Their unique approach positions Deciduous at the forefront of the aging therapeutics market, with promising potential for significant impact and growth.
Something looks off?